Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 2, 2008Cancer

Acute lymphoblastic leukemia and Down syndrome

View Full Paper
Ask AI
Bookmark
Share

Authors

MAMaurizio AricòOspedale G.B. Morgagni - L.PierantoniOZOttavio ZiinoAzienda di Rilievo Nazionale ed Alta SpecializzazioneMVMaria Grazia ValsecchiAzienda Ospedaliera San Gerardo

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Aricò et al. (2008) studied this question.

synapsesocial.com/papers/6a802d462cf87dafd7c8760chttps://doi.org/10.1002/cncr.23587
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Down's syndrome and acute lymphoblastic leukaemia: clinical features and response to treatment2001 · 102 citations
  2. 2Risk-directed therapy for childhood acute lymphoblastic leukemia. Results of the associazione italiana ematologia oncologia pediatrica '82 studies1993 · 18 citations
  3. 3Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.1995 · 105 citations
  4. 4Impact of Minimal Residual Disease (MRD) on Prognosis in Children with Acute Lymphoblastic Leukemia (ALL) According to WBC Count, Age and TEL/AML1 Status at Diagnosis. Results of the AIEOP-BFM ALL 2000 Study.2007 · 3 citations
  5. 5Clinical characteristics and outcome of children with Down syndrome and acute lymphoblastic leukemia: a Children's Cancer Group study2005 · 133 citations